{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"pituitary-adenocarcinoma","columns":[{"gene":"","key":"population-32102d0b4de0c1801164","label":"Pituitary carcinoma","mondoId":"MONDO:0017582","onsetQualifier":null,"originColumnKey":"MONDO:0017582/ORPHA:300385","originalViews":[{"key":"MONDO:0017582/ORPHA:300385","label":"Pituitary carcinoma","scopeLabel":"ORPHA:300385","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["007b6d22db0babc7283d04469ef5800ce27ea05b11e0c52b584b64da5812e970","01a22f89640612b3a85502c0597bfa19a51e7968550b753e1702db275a7e35ed","0c1db80c4b36cc92c4deb885268eff14f38a06e36f8681aa064fd478bc0f97c5","0e0067164dee313b9d59bfdd8a5b075c6548601a578ffca86d7cd38ab79f8d82","24e32a9fdd0b35f86a332915b96cc302551543067114ab825e2fefe09d2d53b4","261859ddad27b482cec09f0273454a13f16181083e023e758fcf499778c65ae1","2e5bc3f44d0e1c9336cab466c923b62c7cbe0cee4457f98ea8da0380c04dcf4b","31595492cf89802bd09545fa17e6ef6db4215f02a6cd4931f5b3bf69ef44451a","3fbced09215762620f08947f9f9749b0f7d8c6492707e026acaff2b1ce0bb1d7","477e8bb0c26565eb7947cd36d31f766b1aac491d7be56e140ce9a81954e48821","4aa006c9b0f3ddcab4584398383c0ced2281de61e53e3b06be4cbed9f21bd805","5444bd2d5c3540a3f8d4b85007b3ccccf6c5ad35ef970ee27250371cd6f04fbd","5c770c2a551ff38aaf432873d4470ffb2b81261c1d51e851ea937a51b143d228","7086059cb5ec3490f2bb01a8ee74b06cfb4889f94e31aad15266a23df684752c","96dfda6c245b9b65cd20c917059b7b3432792ee1cef236082ca1bc03d720be0b","97016764bcf9e0311c0cfc79b3300b439458c57d331411da05a1c5c3edbe501b","9ec745100d376a96b9929845897ced0ebf20d9ac0e6947d9bda3dba76f4d7b76","a3f31e3b0fb52e2a3064c4291ef3b7fac916bd12fc2c319d8303375cbe93956f","a54d11a7e4dff0beb8f91043f14fda936c9154d36319faaf9df89cd91d4b4434","b9243687ba6ff8421e24f9eecd5151b40def475d400d6a0a11f4fac9d3034259","ebe3d0f072d4782af279db139540b3155c40dc228b176e27d9f1d37828a1b1a9","edf196db85324929d440eb28fe31253fc7a8530062140a64b194e19160273292"],"recordQualifiers":{},"scopeLabel":"ORPHA:300385","sourceIds":["ORPHA:300385"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-32102d0b4de0c1801164"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0011442","HP:0001251","HP:0000873","HP:0000845","HP:0012505","HP:0002315","HP:0000365"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":22,"sourceGroups":{"orphanet":22}},"features":[{"hpoId":"HP:0011442","label":"Abnormal central motor function","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0000873","label":"Diabetes insipidus","primary":true},{"hpoId":"HP:0000845","label":"Elevated circulating growth hormone concentration","primary":true},{"hpoId":"HP:0012505","label":"Enlarged pituitary gland","primary":true},{"hpoId":"HP:0002315","label":"Headache","primary":true},{"hpoId":"HP:0000365","label":"Hearing impairment","primary":true},{"hpoId":"HP:0012377","label":"Hemianopia","primary":false},{"hpoId":"HP:0010514","label":"Hyperpituitarism","primary":false},{"hpoId":"HP:0040075","label":"Hypopituitarism","primary":false},{"hpoId":"HP:0003154","label":"Increased circulating ACTH level","primary":false},{"hpoId":"HP:0000870","label":"Increased circulating prolactin concentration","primary":false},{"hpoId":"HP:0100836","label":"Malignant neoplasm of the central nervous system","primary":false},{"hpoId":"HP:0011763","label":"Pituitary carcinoma","primary":false},{"hpoId":"HP:0008291","label":"Pituitary corticotropic cell adenoma","primary":false},{"hpoId":"HP:0011759","label":"Pituitary gonadotropic cell adenoma","primary":false},{"hpoId":"HP:0011760","label":"Pituitary growth hormone cell adenoma","primary":false},{"hpoId":"HP:0006767","label":"Pituitary prolactin cell adenoma","primary":false},{"hpoId":"HP:0011762","label":"Pituitary thyrotropic cell adenoma","primary":false},{"hpoId":"HP:0007987","label":"Progressive visual field defects","primary":false},{"hpoId":"HP:0007663","label":"Reduced visual acuity","primary":false},{"hpoId":"HP:0100561","label":"Spinal cord lesion","primary":false}],"ledeHtml":"A rare adenocarcinoma with poor prognosis, arising from the adenohypophysial cells of the anterior lobe of the pituitary gland or pre-existing adenomas. The majority are hormonally functioning neoplasms, usually producing prolactin or ACTH. The diagnosis is based on the presence of metastases. Syndromes associated with pituitary gland carcinomas include hyperprolactinemia, Cushing disease, and acromegaly.","mondoId":"MONDO:0017582","node":{"canonicalSlug":"pituitary-adenocarcinoma","comparisons":[{"documentSha256":"c798630f64c138209799f7aa3456ab299ec2697af87e32c3fb0101584a7c525f","key":"legacy-pituitary-adenocarcinoma","kind":"legacy","label":"pituitary adenocarcinoma","memberIds":["MONDO:0017582"],"mondoId":"MONDO:0017582","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/pituitary-adenocarcinoma.c798630f64c138209799f7aa3456ab299ec2697af87e32c3fb0101584a7c525f.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Pituitary carcinoma","originalSourceId":"ORPHA:300385","paragraphs":["A rare adenocarcinoma with poor prognosis, arising from the adenohypophysial cells of the anterior lobe of the pituitary gland or pre-existing adenomas. The majority are hormonally functioning neoplasms, usually producing prolactin or ACTH. The diagnosis is based on the presence of metastases. Syndromes associated with pituitary gland carcinomas include hyperprolactinemia, Cushing disease, and acromegaly."],"rawAttribution":"MONDO:0017582","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T15:52:15Z","upstream":"MONDO:0017582","url":"https://rarediseases.info.nih.gov/diseases/9371"},"ownColumnKeys":["population-32102d0b4de0c1801164"],"publication":"published","relationships":[{"kind":"parent","label":"head and neck carcinoma","mondoId":"MONDO:0002038","slug":null},{"kind":"parent","label":"pituitary cancer","mondoId":"MONDO:0002109","slug":"pituitary-cancer"},{"kind":"parent","label":"bone carcinoma","mondoId":"MONDO:0002415","slug":null},{"kind":"parent","label":"adenocarcinoma","mondoId":"MONDO:0004970","slug":null},{"kind":"child","label":"pituitary gland basophilic carcinoma","mondoId":"MONDO:0003202","slug":null},{"kind":"child","label":"ACTH-producing pituitary gland carcinoma","mondoId":"MONDO:0006069","slug":"acth-producing-pituitary-gland-carcinoma"},{"kind":"child","label":"prolactin-producing pituitary gland carcinoma","mondoId":"MONDO:0006388","slug":"prolactin-producing-pituitary-gland-carcinoma"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"007b6d22db0babc7283d04469ef5800ce27ea05b11e0c52b584b64da5812e970","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000365","is_excluded":false,"label":"Hearing impairment","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"01a22f89640612b3a85502c0597bfa19a51e7968550b753e1702db275a7e35ed","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012377","is_excluded":false,"label":"Hemianopia","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0c1db80c4b36cc92c4deb885268eff14f38a06e36f8681aa064fd478bc0f97c5","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008291","is_excluded":false,"label":"Pituitary corticotropic cell adenoma","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0e0067164dee313b9d59bfdd8a5b075c6548601a578ffca86d7cd38ab79f8d82","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0006767","is_excluded":false,"label":"Pituitary prolactin cell adenoma","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"24e32a9fdd0b35f86a332915b96cc302551543067114ab825e2fefe09d2d53b4","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0000873","is_excluded":false,"label":"Diabetes insipidus","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"261859ddad27b482cec09f0273454a13f16181083e023e758fcf499778c65ae1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2e5bc3f44d0e1c9336cab466c923b62c7cbe0cee4457f98ea8da0380c04dcf4b","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007663","is_excluded":false,"label":"Reduced visual acuity","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"31595492cf89802bd09545fa17e6ef6db4215f02a6cd4931f5b3bf69ef44451a","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0040075","is_excluded":false,"label":"Hypopituitarism","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3fbced09215762620f08947f9f9749b0f7d8c6492707e026acaff2b1ce0bb1d7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100561","is_excluded":false,"label":"Spinal cord lesion","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"477e8bb0c26565eb7947cd36d31f766b1aac491d7be56e140ce9a81954e48821","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002315","is_excluded":false,"label":"Headache","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4aa006c9b0f3ddcab4584398383c0ced2281de61e53e3b06be4cbed9f21bd805","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0100836","is_excluded":false,"label":"Malignant neoplasm of the central nervous system","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5444bd2d5c3540a3f8d4b85007b3ccccf6c5ad35ef970ee27250371cd6f04fbd","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011760","is_excluded":false,"label":"Pituitary growth hormone cell adenoma","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5c770c2a551ff38aaf432873d4470ffb2b81261c1d51e851ea937a51b143d228","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0011759","is_excluded":false,"label":"Pituitary gonadotropic cell adenoma","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7086059cb5ec3490f2bb01a8ee74b06cfb4889f94e31aad15266a23df684752c","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012505","is_excluded":false,"label":"Enlarged pituitary gland","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"96dfda6c245b9b65cd20c917059b7b3432792ee1cef236082ca1bc03d720be0b","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007987","is_excluded":false,"label":"Progressive visual field defects","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"97016764bcf9e0311c0cfc79b3300b439458c57d331411da05a1c5c3edbe501b","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003154","is_excluded":false,"label":"Increased circulating ACTH level","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9ec745100d376a96b9929845897ced0ebf20d9ac0e6947d9bda3dba76f4d7b76","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000845","is_excluded":false,"label":"Elevated circulating growth hormone concentration","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a3f31e3b0fb52e2a3064c4291ef3b7fac916bd12fc2c319d8303375cbe93956f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011442","is_excluded":false,"label":"Abnormal central motor function","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a54d11a7e4dff0beb8f91043f14fda936c9154d36319faaf9df89cd91d4b4434","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0011763","is_excluded":false,"label":"Pituitary carcinoma","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b9243687ba6ff8421e24f9eecd5151b40def475d400d6a0a11f4fac9d3034259","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000870","is_excluded":false,"label":"Increased circulating prolactin concentration","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ebe3d0f072d4782af279db139540b3155c40dc228b176e27d9f1d37828a1b1a9","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010514","is_excluded":false,"label":"Hyperpituitarism","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"edf196db85324929d440eb28fe31253fc7a8530062140a64b194e19160273292","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:300385","disease_name":"Pituitary carcinoma","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0011762","is_excluded":false,"label":"Pituitary thyrotropic cell adenoma","onset_id":null,"reference":"ORPHA:300385","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9371\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0017582\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0017582</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare adenocarcinoma with poor prognosis, arising from the adenohypophysial cells of the anterior lobe of the pituitary gland or pre-existing adenomas. The majority are hormonally functioning neoplasms, usually producing prolactin or ACTH. The diagnosis is based on the presence of metastases. Syndromes associated with pituitary gland carcinomas include hyperprolactinemia, Cushing disease, and acromegaly.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9371\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"pituitary-adenocarcinoma","sourceDocuments":[{"name":"GARD: Pituitary carcinoma","reviewed":null,"source_release":"2026-10-21T15:52:15Z","url":"https://rarediseases.info.nih.gov/diseases/9371"},{"name":"MONDO: pituitary adenocarcinoma","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0017582"}],"sourceNote":"","synonyms":["carcinoma of pituitary","carcinoma of pituitary gland","carcinoma of the pituitary","carcinoma of the pituitary gland","pituitary adenocarcinoma (disease)","pituitary carcinoma","pituitary gland adenocarcinoma","pituitary gland carcinoma","PTCA"],"takeawayHtml":"","title":"pituitary adenocarcinoma"},"schemaVersion":1}
